DNTH Operating Cash Flow (Statement)
Dianthus Therapeutics Inc · Operating Cash Flow (Statement)
DNTH Operating Cash Flow (Statement)
Latest reported-$48.98Mperiod ending
DNTH Quarterly Cash from Operations (-$4.03M → -$48.98M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
DNTH operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -48,981,000 | |
| -28,856,000 | |
| -46,983,000 | |
| -30,555,000 | |
| -23,892,000 | |
| -27,630,000 | |
| -27,444,000 | |
| -21,267,000 | |
| -14,528,000 | |
| -14,941,000 | |
| -11,854,000 | |
| 1,497,000 | |
| -4,731,000 | |
| -10,284,000 | |
| -8,851,000 | |
| 16,375,000 | |
| -16,853,000 | |
| -19,741,000 | |
| -15,690,000 | |
| -14,067,000 | |
| -13,000,000 | |
| -16,774,000 | |
| -13,733,000 | |
| -14,428,000 | |
| -19,205,000 | |
| -16,657,000 | |
| -15,627,000 | |
| -11,507,000 | |
| -15,033,000 | |
| -14,936,000 | |
| -12,624,000 | |
| -10,549,000 | |
| -9,109,000 | |
| -9,604,000 | |
| -8,232,000 | |
| -5,443,000 | |
| -4,558,000 | |
| -4,030,000 |